ID   RUTF_STAND              Reviewed;         181 AA.
AC   D7A989;
DT   11-JAN-2011, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 1.
DT   07-JAN-2015, entry version 26.
DE   RecName: Full=FMN reductase (NADH) RutF {ECO:0000255|HAMAP-Rule:MF_00833};
DE            EC=1.5.1.42 {ECO:0000255|HAMAP-Rule:MF_00833};
DE   AltName: Full=FMN reductase {ECO:0000255|HAMAP-Rule:MF_00833};
DE   AltName: Full=NADH-flavin reductase RutF {ECO:0000255|HAMAP-Rule:MF_00833};
DE   AltName: Full=NADH:flavin oxidoreductase {ECO:0000255|HAMAP-Rule:MF_00833};
GN   Name=rutF {ECO:0000255|HAMAP-Rule:MF_00833};
GN   OrderedLocusNames=Snov_3377;
OS   Starkeya novella (strain ATCC 8093 / DSM 506 / CCM 1077 / IAM 12100 /
OS   NBRC 12443 / NCIB 9113).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales;
OC   Xanthobacteraceae; Starkeya.
OX   NCBI_TaxID=639283;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 8093 / DSM 506 / CCM 1077 / IAM 12100 / NBRC 12443 / NCIB
RC   9113;
RG   US DOE Joint Genome Institute;
RA   Lucas S., Copeland A., Lapidus A., Cheng J.-F., Bruce D., Goodwin L.,
RA   Pitluck S., Davenport K., Brettin T., Detter J.C., Han C., Tapia R.,
RA   Land M., Hauser L., Kyrpides N., Ivanova N., Beatson S., Kappler U.,
RA   Woyke T.;
RT   "Complete sequence of Starkeya novella DSM 506.";
RL   Submitted (MAY-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes the reduction of FMN to FMNH2 which is used to
CC       reduce pyrimidine by RutA via the Rut pathway. {ECO:0000255|HAMAP-
CC       Rule:MF_00833}.
CC   -!- CATALYTIC ACTIVITY: FMNH(2) + NAD(+) = FMN + NADH.
CC       {ECO:0000255|HAMAP-Rule:MF_00833}.
CC   -!- SIMILARITY: Belongs to the non-flavoprotein flavin reductase
CC       family. RutF subfamily. {ECO:0000255|HAMAP-Rule:MF_00833}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP002026; ADH90651.1; -; Genomic_DNA.
DR   RefSeq; WP_013168152.1; NC_014217.1.
DR   RefSeq; YP_003695270.1; NC_014217.1.
DR   ProteinModelPortal; D7A989; -.
DR   EnsemblBacteria; ADH90651; ADH90651; Snov_3377.
DR   GeneID; 9334469; -.
DR   KEGG; sno:Snov_3377; -.
DR   PATRIC; 38259345; VBIStaNov45716_3374.
DR   HOGENOM; HOG000115783; -.
DR   KO; K09024; -.
DR   OMA; PAGRFGF; -.
DR   BioCyc; SNOV639283:GCS4-3419-MONOMER; -.
DR   Proteomes; UP000006633; Chromosome.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0008752; F:FMN reductase activity; IEA:InterPro.
DR   GO; GO:0042602; F:riboflavin reductase (NADPH) activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0019740; P:nitrogen utilization; IEA:UniProtKB-HAMAP.
DR   GO; GO:0006212; P:uracil catabolic process; IEA:UniProtKB-HAMAP.
DR   Gene3D; 2.30.110.10; -; 1.
DR   HAMAP; MF_00833; RutF; 1.
DR   InterPro; IPR002563; Flavin_Rdtase_FMN-bd.
DR   InterPro; IPR019917; RutF.
DR   InterPro; IPR012349; Split_barrel_FMN-bd.
DR   Pfam; PF01613; Flavin_Reduct; 1.
DR   SMART; SM00903; Flavin_Reduct; 1.
DR   SUPFAM; SSF50475; SSF50475; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Flavoprotein; FMN; NAD; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN         1    181       FMN reductase (NADH) RutF.
FT                                /FTId=PRO_0000403048.
SQ   SEQUENCE   181 AA;  18490 MW;  252FBC3325BDA883 CRC64;
     MARSAPLDET NSGAAKAPAI SREQYRDAMA RLGAAVTIVT TDGPGGRAGF TASAVCSVTD
     SPPTLLVCLN KSSSAAHAVH ANGVVCVNTL AAGHEALSNL FGGRTPPEER FAAGQWHTSA
     TGAPILVGAV VAFDCRIVKT VEVGTHDVLF CEVVGLAEGG GREGLIYFSR RYHAVAGTPE
     G
//
